New Eye Drops Target T-Cell Inflammation to Treat Dry Eye Disease
At the heart of dry eye disease lies a dysregulated immune-inflammatory response on the ocular surface—particularly aberrant T-cell activation, which initiates and perpetuates a cascade of inflammator